Irreversible agonist
Irreversible agonists are a type of pharmacological agent that bind permanently to their target receptors, causing a sustained activation of the receptor and an irreversible change in the receptor's response. This is in contrast to reversible agonists, which bind temporarily to their target receptors and can be removed to reverse their effects.
Mechanism of Action[edit]
Irreversible agonists work by forming a covalent bond with their target receptor. This bond is not easily broken, meaning that the agonist remains bound to the receptor indefinitely. This results in a sustained activation of the receptor, which can lead to a prolonged physiological response.
The mechanism of action of irreversible agonists is different from that of partial agonists and full agonists. Partial agonists only partially activate their target receptors, while full agonists fully activate their target receptors but can be removed to reverse their effects.
Applications[edit]
Irreversible agonists have a number of potential applications in medicine. Because they cause a sustained activation of their target receptors, they can be used to produce a long-lasting therapeutic effect. This can be particularly useful in the treatment of chronic conditions, where a sustained therapeutic effect is desirable.
However, the use of irreversible agonists also carries risks. Because they bind permanently to their target receptors, they can potentially cause overactivation of the receptor, leading to adverse effects. This makes the use of irreversible agonists a delicate balancing act between achieving the desired therapeutic effect and avoiding potential adverse effects.
Examples[edit]
One example of an irreversible agonist is phenylephrine, which is used as a decongestant and to increase blood pressure. Phenylephrine binds irreversibly to adrenergic receptors, causing a sustained activation of these receptors and a prolonged physiological response.
Another example is isoflurane, an anesthetic that binds irreversibly to GABA receptors, causing a sustained activation of these receptors and a prolonged anesthetic effect.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
